Cargando…
PCSK9 Inhibitors: Clinical Relevance, Molecular Mechanisms, and Safety in Clinical Practice
Coronary artery disease (CAD) is one of the leading causes of mortality. High circulating levels of low-density lipoprotein (LDL) in the blood are associated with cardiovascular mortality, whether through an etiological role or through its association with the progression of CAD per se. Randomized c...
Autores principales: | Ferrari, Filipe, Stein, Ricardo, Motta, Marcelo Trotte, Moriguchi, Emilio Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459431/ https://www.ncbi.nlm.nih.gov/pubmed/30843929 http://dx.doi.org/10.5935/abc.20190029 |
Ejemplares similares
-
Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study
por: Blanco-Ruiz, Marina, et al.
Publicado: (2021) -
Indications of PCSK9 Inhibitors for Patients at High and Very High
Cardiovascular Risk
por: Behr, Paulo Eduardo Ballvé, et al.
Publicado: (2018) -
Biochemical and Molecular Mechanisms of Glucose Uptake Stimulated by Physical Exercise in Insulin Resistance State: Role of Inflammation
por: Ferrari, Filipe, et al.
Publicado: (2019) -
Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018) -
Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)